Response to Letter Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”
Circulation: Cardiovascular Interventions · 2024
DOI: 10.1161/circinterventions.124.014522 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Vasu Nandhakumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute of Cardio-Vascular Diseases, The Madras Medical Mission Hospital, Chennai, Tamilnadu, India. Hauptthemen laut MEDLINE: Mitral Valve, Intracranial Embolism, Cardiac Catheterization, Heart Valve Prosthesis. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Institute of Cardio-Vascular Diseases, The Madras Medical Mission Hospital, Chennai, Tamilnadu, India.
ORCID-Profile: Vasu Nandhakumar, Mullasari S Ajit
Zitieren
APA
Nandhakumar, V., Kalidoss, L., & Ajit, M. S. (2024). Response to Letter Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.124.014522
Vancouver
Nandhakumar V, Kalidoss L, Ajit MS. Response to Letter Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.124.014522
BibTeX
@article{Nandhakumar2024,
author = {Nandhakumar, Vasu and Kalidoss, Latchumanadhas and Ajit, Mullasari S},
title = {Response to Letter Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”},
journal = {Circulation: Cardiovascular Interventions},
year = {2024},
doi = {10.1161/circinterventions.124.014522}
}
EUVIMED